CaRe Clinic Joins hyperCORE International to Enhance Global Clinical Research Capabilities
TL;DR
Joining hyperCORE International gives CaRe Clinic a competitive advantage in expanding global reach and capabilities through alliance partnerships.
CaRe Clinic's community-centric recruitment strategy, state-of-the-art research centers, and strong partnerships contribute to its success in redefining medical research in Canada.
CaRe Clinic's partnership with hyperCORE International aims to pioneer breakthroughs that will benefit patients worldwide, highlighting Canada's robust clinical research ecosystem on the global stage.
CaRe Clinic's broad combination of investigators' patient databases and access to a reservoir of over 1.8 million potential patients makes it a key player in advancing clinical research.
Found this article helpful?
Share it with your network and spread the knowledge!
CaRe Clinic, a prominent multi-specialty research organization based in Alberta, Canada, has joined the collaborative super network of hyperCORE International, marking a significant expansion of global clinical trial capabilities. This strategic alliance brings together CaRe Clinic's two state-of-the-art research centers serving Calgary and Red Deer with hyperCORE's extensive international network, creating enhanced opportunities for clinical research advancement across multiple therapeutic areas.
The organization brings substantial value to the partnership through its proven track record of participating in hundreds of clinical trials across various medical fields including women's health, dermatology, general medicine, vaccines, infectious diseases, and migraine treatments. One of CaRe Clinic's most significant assets is its extensive patient database, which provides access to a potential patient pool of over 1.8 million individuals through investigators' databases and strong partnerships with affiliated clinics. This vast resource, combined with the organization's community-centric recruitment strategy, offers unparalleled participant recruitment capabilities across a wide range of medical indications.
Troy Hamilton, Director of Operations at CaRe Clinic, emphasized the partnership's significance for global clinical research collaboration and the sharing of best practices across borders. The inclusion of CaRe Clinic into hyperCORE International's network substantially expands hyperCORE's presence in Canada with multiple locations and a multi-therapeutic offering. hyperCORE International, already an industry leader in providing Phase I-IV clinical trial services, now extends its global footprint across two continents and five countries with more than 120 active research sites.
Carlos Orantes, President of hyperCORE and CEO at alliance partner Alcanza Clinical Research, expressed enthusiasm about the immediate expansion of hyperCORE's Canadian footprint and the addition of a solid partner to the team. The collaboration leverages hyperCORE International's decades of clinical research experience, with alliance partners having completed more than 7,000 studies and evaluated thousands of new drugs and treatments in over 150,000 randomized patients.
This partnership is positioned to accelerate the pace of clinical research and drug development, potentially leading to faster breakthroughs in medical treatments across various therapeutic areas. By combining CaRe Clinic's robust patient database and recruitment capabilities with hyperCORE's extensive experience and global network, the alliance addresses critical challenges in clinical trials such as patient recruitment and retention. The collaboration represents a trend toward more integrated, efficient, and globally connected clinical research networks, highlighting the importance of international cooperation in advancing medical science and bringing new treatments to patients worldwide more rapidly and effectively.
Curated from 24-7 Press Release
